Publications

Publications Reborne 2014

Effects of a ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin.

Bassi G, Guilloton F, Menard C, Di Trapani M, Deschaseaux F, Sensebe L, Schrezenmeier H, Giordano R, Bourin P, Dominici M, Tarte K, Krampera M.

Tissue Eng Part A. 2014 Oct 16. [Epub ahead of print]

New preclinical porcine model of femoral head osteonecrosis to test mesenchymal stromal cell efficiency in regenerative medicine.

Poignard A, Lebouvier A, Cavet M, Rahmouni A, Flouzat Lachaniette CH, Bierling P, Rouard H, Hernigou P, Chevallier N.

International Orthopaedics (SICOT). DOI 10.1007/s00264-014-2352-8. 2014 May 9. [Epub ahead of print]

Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells.

Gómez-Barrena E, Solá CA, Bunu CP.

International Orthopaedics (SICOT). DOI 10.1007/s00264-014-2332-z. 2014 Apr 15. [Epub ahead of print]

Publications Reborne 2013

Influence of untranslated regions on retroviral mRNA transfer and expression.

Prel A, Sensébé L, Pagčs JC.

BMC Biotechnol. 2013 Apr 16;13:35. doi: 10.1186/1472-6750-13-35.

Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation.

Leotot J, Coquelin L, Bodivit G, Bierling P, Hernigou P, Rouard H, Chevallier N.

Acta Biomater. 2013 May;9(5):6630-40. doi: 10.1016/j.actbio.2013.02.003. Epub 2013 Feb 9.

CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human.

Varin A, Pontikoglou C, Labat E, Deschaseaux F, Sensebé L.

PLoS One.2013 Aug 5;8(8):e72831. doi: 10.1371/journal.pone.0072831. Print 2013.

Cell therapy for bone repair.

Rosset P, Deschaseaux F, Layrolle P.

Orthop Traumatol Surg Res. 2014 Feb;100(1S):S107-S112. doi: 10.1016/j.otsr.2013.11.010. Epub 2014 Jan 7.

Pre-vascularization of bone tissue-engineered constructs.

Brennan MA, Davaine JM, Layrolle P.

Stem Cell Res Ther. 2013 Aug 14;4(4):96. [Epub ahead of print]

[Intra-articular distal radial fracture with lunate fossa rotated, about 4 cases: interest of surgical procedure by volar medial approach].

Uzel AP, Bulla A, Tchéro H, Tsiaviry P, Bourges C, Daculsi G.

Chir Main. 2013 Feb;32(1):37-43. doi: 10.1016/j.main.2012.12.003. Epub 2013 Jan 7. French.

Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest.

Ragni E, Viganň M, Parazzi V, Montemurro T, Montelatici E, Lavazza C, Budelli S, Vecchini A, Rebulla P, Giordano R, Lazzari L.

Int J Biochem Cell Biol. 2013 Nov;45(11):2456-66. doi: 10.1016/j.biocel.2013.07.024. Epub 2013 Aug 11.

What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes.

Ragni E, Viganň M, Rebulla P, Giordano R, Lazzari L.

J Cell Mol Med. 2013 Jan;17(1):168-80. doi: 10.1111/j.1582-4934.2012.01660.x. Epub 2013 Jan 11.

Differential microRNA signature of human mesenchymal stem cells from different sources reveals an “environmental-niche memory” for bone marrow stem cells.

Ragni E, Montemurro T, Montelatici E, Lavazza C, Viganň M, Rebulla P, Giordano R, Lazzari L.

Exp Cell Res. 2013 Jun 10;319(10):1562-74. doi: 10.1016/j.yexcr.2013.04.002. Epub 2013 Apr 8.

Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.

Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebé L, Tarte K, Krampera M.

Stem Cells Dev. 2013 Jun 15;22(12):1789-801. doi: 10.1089/scd.2012.0594. Epub 2013 Feb 25.

Regulation and function of immunosuppressivemoleculehuman leukocyte antigen G5 in human bone tissue.

Deschaseaux F, Gaillard J, Langonné A, Chauveau C, Naji A, Bouacida A, Rosset P, Heymann D, De Pinieux G, Rouas-Freiss N, Sensébé L.

FASEB J. 2013 Aug;27(8):2977-87. doi: 10.1096/fj.13-227264. Epub 2013 Apr 16.

Concise review: combining human leukocyte antigen G and mesenchymalstemcellsfor immunosuppressant biotherapy.

Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F.

StemCells. 2013 Nov;31(11):2296-303. doi: 10.1002/stem.1494.

Immunologicalcharacterization of multipotent mesenchymal stromal cells–The International Society for Cellular Therapy (ISCT) working proposal.

Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L; MSC Committee of the International Society for Cellular Therapy (ISCT).

Cytotherapy. 2013 Sep;15(9):1054-61. doi: 10.1016/j.jcyt.2013.02.010. Epub 2013 Apr 17.

MSCs: science and trials.

Phinney DG, Galipeau J, Krampera M, Martin I, Shi Y, Sensebe L.

Nat Med. 2013 Jul;19(7):812. doi: 10.1038/nm.3220. No abstract available.

Comparative study of immuneregulatorypropertiesof stem cellsderived from differenttissues.

Di Trapani M, Bassi G, Ricciardi M, Fontana E, Bifari F, Pacelli L, Giacomello L, Pozzobon M, Féron F, De Coppi P, Anversa P, Fumagalli G, Decimo I, Menard C, Tarte K, Krampera M.

Stem Cells Dev. 2013 Nov 15;22(22):2990-3002. doi: 10.1089/scd.2013.0204. Epub 2013 Aug 9.

Pleiotrophin Commits Human Bone Marrow Mesenchymal Stromal Cells towards Hypertrophy during Chondrogenesis.

Bouderlique T, Henault E, Lebouvier A, Frescaline G, Bierling P, Rouard H, Courty J, Albanese P, Chevallier N.

PLoS One. 2014 Feb 7;9(2):e88287. doi: 10.1371/journal.pone.0088287. eCollection 2014.

GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair.

Wiehe JM, Kaya Z, Homann JM, Wöhrle J, Vogt K, Nguyen T, Rottbauer W, Torzewski J, Fekete N, Rojewski M, Schrezenmeier H, Moepps B, Zimmermann O.

Int J Cardiol. 2013 Sep 1;167(5):2073-81. doi: 10.1016/j.ijcard.2012.05.065. Epub 2012 Jun 4.

Publications Reborne 2012
Polymeric additives to enhance the functional properties of calcium phosphate cements.

Perez RA, Kim HW, Ginebra MP.

J Tissue Eng. 2012;3(1):2041731412439555. doi: 10.1177/2041731412439555.

Epub 2012Mar 20.PMID:22511991[PubMed]

In vivo performance of microstructured calcium phosphate formulated in novel water-free carriers.

Davison N, Yuan H, de Bruijn JD, Barrere-de Groot F.

Acta Biomater. 2012 Jul;8(7):2759-69. doi: 10.1016/j.actbio.2012.04.007. Epub 2012 Apr 7.

Novel analysis model for implant osseointegration using ectopic bone formation via the recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system in rats: a proof-of-concept study.

Park JC, Lee JB, Daculsi G, Oh SY, Cho KS, Im GI, Kim BS, Kim CS.

J Periodontal Implant Sci. 2012Aug;42(4):136-43. doi: 10.5051/jpis.2012.42.4.136. Epub 2012 Aug 31.PMID:22977743[PubMed]

Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.

Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT.

Cytotherapy. 2012 May;14(5):540-54. doi: 10.3109/14653249.2012.655420. Epub 2012 Feb 2.

Osteoblastic differentiation and potent osteogenicity of three-dimensional hBMSC-BCP particle constructs.

Cordonnier T, Langonné A, Corre P, Renaud A, Sensebé L, Rosset P, Layrolle P, Sohier J.

J Tissue Eng Regen Med. 2012 Jun 11. doi: 10.1002/term.1529. [Epub ahead of print]

Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells.

Bouacida A, Rosset P, Trichet V, Guilloton F, Espagnolle N, Cordonier T, Heymann D, Layrolle P, Sensébé L, Deschaseaux F.

PLoS One. 2012;7(11):e48648. doi: 10.1371/journal.pone.0048648. Epub 2012 Nov 7.

Publications Reborne 2011
Scaffold Effects of Microporous BiphasicCalcium … – OMICS Group

G.Daculsi, A.P Uzel, J.C Cursolle, E. Goyenvalle, and E. Auguado

Ashdin Publishing

Bioceramics Development and Applications

Vol.1 (2011), Article ID D1101176, 4 pages

Doi: 10.4303/bda/D110176

Bone regeneration and stem cells.

Arvidson K, Abdallah BM, Applegate LA, Baldini N, Cenni E, Gomez-Barrena E, Granchi D, Kassem M, Konttinen YT, Mustafa K, Pioletti DP, Sillat T, Finne-Wistrand A.

J Cell Mol Med. 2011 Apr;15(4):718-46. doi: 10.1111/j.1582-4934.2010.01224.x. Review.

PMID:21129153[PubMed – indexed for MEDLINE]

Fibre-reinforced calcium phosphate cements: a review.

Canal C, Ginebra MP.
J MechBehavBiomed Mater. 2011 Nov;4(8):1658-71. doi: 10.1016/j.jmbbm.2011.06.023. Epub 2011 Jul 14. Review.

Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology.

Gómez-Barrena E, Rosset P, Müller I, Giordano R, Bunu C, Layrolle P, Konttinen YT, Luyten FP.
J Cell Mol Med. 2011 Jun;15(6):1266-86. doi: 10.1111/j.1582-4934.2011.01265.x. Review.

Publications Reborne 2010

Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate.

Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, Bierling P, Hernigou P, Layrolle P, Rouard H.

Biomaterials. 2010 Jan; 31(2):270-8. doi: 10.1016/j.biomaterials.2009.09.043. Epub 2009 Sep 26.PMID:19783038

Platelet gel from cord blood: a novel tool for tissue engineering.

Parazzi V, Lazzari L, Rebulla P.

Platelets. 2010; 21(7):549-54. doi: 10.3109/09537104.2010.514626.

PMID:20873963[PubMed – indexed for MEDLINE]